According to a study, women show better results than men with device therapy to prevent the progression of mild heart failure. Men received some benefit from the therapy; women with mild heart disease who had a cardiac resynchronization device combined with a defibrillator implanted had a 70 percent reduction in heart failure alone and a 72 percent reduction in death demo any cause. The device is already approved to treat patients with severe heart failure

Dr. Wojciech Zareba, co author of the study said “Anecdotally, we know that women are offered devices to treat heart failure less often than men. We're hopeful that these results will change the mindset of physicians and that they will apply this type of therapy as indicated in women as well as in men”.

If otherwise also known as cardiac remodeling, in women with mild heart failure, CRT –D therapy effectively prevented deterioration of the heart and the study was presented at the Heart Rhythm Society’s 31st Annual Scientific Sessions. In Denver, there are around 700,000 people in Britain with heart failure and it affects slightly fewer women than men as the results were presented at the Heart Rhythm Society meeting.

Women may place less emphasis on their own health that men and so their disease is more advanced when they are finally diagnosed and in turn see a greater benefit when they are treated as the authors believe that heart conditions affect men and women differently which may account for the reason that the device is more effective in women.